Hydroxychloroquine sulfate vs Adalimumab
National NHS prescribing compared (Prescription Cost Analysis)
Hydroxychloroquine sulfate was dispensed 22,088.4× as often as Adalimumab in March 2026 — 110,442 items versus 5 in England.
110,442items
Hydroxychloroquine sulfate · March 2026
NHSBSA Prescription Cost Analysis
5items
Adalimumab · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Hydroxychloroquine sulfate versus Adalimumab: national items dispensed by month
▬ Hydroxychloroquine sulfate · ╌ Adalimumab
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Hydroxychloroquine sulfate | Adalimumab |
|---|---|---|
| Items, March 2026 | 110,442 | 5 |
| Items, last 12 months | 1,304,762 | 34 |
| Net ingredient cost, March 2026 | £324,421 | £2,993 |
See the full profile for Hydroxychloroquine sulfate or Adalimumab.